Skip to main content
Michael Saag, MD, Infectious Disease, Birmingham, AL

Michael S Saag MD

HIV/AIDS Medicine


Professor of Medicine, University Alabama

Join to view full profile
  • 619 19th St SBirmingham, AL 35233

  • Phone+1 205-934-6600

Dr. Saag is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Alabama Hospital (Birmingham)
    University of Alabama Hospital (Birmingham)Fellowship, Infectious Disease, 1985 - 1987
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 1981 - 1984
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 1981

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1982 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013, 2016
  • CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2013, 2016
  • CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2013, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Misguided Use of Hydroxychloroquine for COVID-19  
    Michael Saag, MD, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults  
    Michael S Saag, Melanie A Thompson, Constance A Benson, Susan P Buchbinder, Joseph J Eron, Donna M Jacobsen, JAMA
  • Alcohol Use Patterns and Subsequent Sexual Behaviors Among Women, Men Who Have Sex with Men and Men Who Have Sex with Women Engaged in Routine HIV Care in the United S...  
    Heidi E Hutton, Karen L Cropsey, Katerina Christopoulos, W Christopher Mathews, Geetanjali Chander, Michael Saag, Heidi M Crane, AIDS and Behavior

Lectures

  • Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment—Reply 
    University of Alabama at Birmingham, Birmingham, AL - 5/15/2014

Press Mentions

  • Next-Gen HIV Treatment: Breakthroughs with Dr. Judith Currier
    Next-Gen HIV Treatment: Breakthroughs with Dr. Judith CurrierJune 4th, 2025
  • Five Years After the COVID-19 Pandemic Began, a Doctor Warns Mistrust in Medicine Remains
    Five Years After the COVID-19 Pandemic Began, a Doctor Warns Mistrust in Medicine RemainsMarch 12th, 2025
  • HIV and Opioid Use Disorder: Screening Tools, Chronic Pain Management, and Access to Care in the Outpatient Setting
    HIV and Opioid Use Disorder: Screening Tools, Chronic Pain Management, and Access to Care in the Outpatient SettingMay 10th, 2023

Grant Support

  • CFAR Network of Integrated Clinical Systems (CNICS)UNIVERSITY OF ALABAMA AT BIRMINGHAM2006–2026
  • Alabama-Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
  • Integration Of Evidence-Based Alcohol Interventions Into HIV CareNational Institute On Alcohol Abuse And Alcoholism2011
  • Recent Advances In AIDS And HIV ResearchNational Institute Of Allergy And Infectious Diseases2009–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2009–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: